AbbVie is big pharma’s first mover in ‘in situ’ cell therapy

AbbVie has signed a wide-ranging collaboration with Umoja Biopharma in the area of ‘in situ’ or in vivo cell therapy, an emerging strategy that does away with the need to harvest, modify, and grow cells outside the body.